InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Chardonnet Laurent, Chief Financial Officer. Officer active across 1 companies, notably Prelude Therapeutics Inc. Cumulatively, 4 reports have been logged. Total volume traded: €40k. The latest transaction was disclosed on 1 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€39,70310,000 shares@ €3.97030.011% mcap20.6% of flow
Common Stock
SEC:0001562180-22-004627:0·
Ideal exit: 26 Feb 2023 (T+270)
€44,2046,500 shares@ €6.80060.012% mcap23.0% of flow
Common Stock
SEC:0001209191-22-020585:0·
€54,2795,000 shares@ €10.85590.015% mcap100.0% of flow
Common Stock
SEC:0001209191-21-069548·
€54,2795,000 shares@ €10.85590.015% mcap28.2% of flow
Common Stock
SEC:0001209191-21-069548:0·
4 of 4 declarations
About Chardonnet Laurent
Laurent Chardonnet is the Chief Financial Officer at Prelude Therapeutics Inc. He is responsible for financial management and strategy of the company. His role is crucial in ensuring financial health and growth.
